[Relationship between ion channel properties and the structure of the lactone ring of polyene antibiotic molecules]. 1978

M P Borisova, and L N Ermishkin, and A Ia Sil'bershteĭn, and Kh M Kasumov, and V M Potseluev

Properties of ionic channels created by amphoterecin B, nystatine and mycoheptin in phospholipid--cholesterol bilayer have been compared. Ionic conductivity and selectivity of channels as well as the frequency of transitions between an open state and a closed one depend on lacton ring structure. Appearance of one more carbonyl group in mycoheptin molecule leads to a decrease of channel anion permeability. Any pair of these antibiotics being added into different aqueous solutions create combined channels. These data confirm hypothesis that polyene antibiotics create channels of two half-pores formed in different monolayers of the membrane.

UI MeSH Term Description Entries
D007473 Ion Channels Gated, ion-selective glycoproteins that traverse membranes. The stimulus for ION CHANNEL GATING can be due to a variety of stimuli such as LIGANDS, a TRANSMEMBRANE POTENTIAL DIFFERENCE, mechanical deformation or through INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS. Membrane Channels,Ion Channel,Ionic Channel,Ionic Channels,Membrane Channel,Channel, Ion,Channel, Ionic,Channel, Membrane,Channels, Ion,Channels, Ionic,Channels, Membrane
D007783 Lactones Cyclic esters of hydroxy carboxylic acids, containing a 1-oxacycloalkan-2-one structure. Large cyclic lactones of over a dozen atoms are MACROLIDES. Lactone
D008567 Membranes, Artificial Artificially produced membranes, such as semipermeable membranes used in artificial kidney dialysis (RENAL DIALYSIS), monomolecular and bimolecular membranes used as models to simulate biological CELL MEMBRANES. These membranes are also used in the process of GUIDED TISSUE REGENERATION. Artificial Membranes,Artificial Membrane,Membrane, Artificial
D009761 Nystatin Macrolide antifungal antibiotic complex produced by Streptomyces noursei, S. aureus, and other Streptomyces species. The biologically active components of the complex are nystatin A1, A2, and A3. Fungicidin,Mycostatin,Nilstat,Nystatin A1,Nystatin A2,Nystatin A3,Nystatin G,Stamicin,Stamycin
D011090 Polyenes Hydrocarbons with more than one double bond. They are a reduced form of POLYYNES. Cumulenes
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D004573 Electrolytes Substances that dissociate into two or more ions, to some extent, in water. Solutions of electrolytes thus conduct an electric current and can be decomposed by it (ELECTROLYSIS). (Grant & Hackh's Chemical Dictionary, 5th ed) Electrolyte
D000666 Amphotericin B Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela. Amphocil,Amphotericin,Amphotericin B Cholesterol Dispersion,Amphotericin B Colloidal Dispersion,Fungizone
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

M P Borisova, and L N Ermishkin, and A Ia Sil'bershteĭn, and Kh M Kasumov, and V M Potseluev
November 1986, Antibiotiki i meditsinskaia biotekhnologiia = Antibiotics and medical biotechnology,
M P Borisova, and L N Ermishkin, and A Ia Sil'bershteĭn, and Kh M Kasumov, and V M Potseluev
September 2001, Acta pharmacologica Sinica,
M P Borisova, and L N Ermishkin, and A Ia Sil'bershteĭn, and Kh M Kasumov, and V M Potseluev
January 1989, Biopolymers,
M P Borisova, and L N Ermishkin, and A Ia Sil'bershteĭn, and Kh M Kasumov, and V M Potseluev
January 1981, Antibiotiki,
M P Borisova, and L N Ermishkin, and A Ia Sil'bershteĭn, and Kh M Kasumov, and V M Potseluev
January 2010, International journal of antimicrobial agents,
M P Borisova, and L N Ermishkin, and A Ia Sil'bershteĭn, and Kh M Kasumov, and V M Potseluev
June 1981, Antibiotiki,
M P Borisova, and L N Ermishkin, and A Ia Sil'bershteĭn, and Kh M Kasumov, and V M Potseluev
October 2018, Inorganic chemistry,
M P Borisova, and L N Ermishkin, and A Ia Sil'bershteĭn, and Kh M Kasumov, and V M Potseluev
January 1964, Medicina experimentalis : International journal of experimental medicine,
M P Borisova, and L N Ermishkin, and A Ia Sil'bershteĭn, and Kh M Kasumov, and V M Potseluev
May 2009, Biochimica et biophysica acta,
M P Borisova, and L N Ermishkin, and A Ia Sil'bershteĭn, and Kh M Kasumov, and V M Potseluev
September 2006, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!